C. Burg et al., LEUKEMIA INHIBITORY FACTOR DERIVED FROM RAT COLON-CARCINOMA CELLS INCREASES HOST SUSCEPTIBILITY TO TUMOR-GROWTH, Cytokine, 7(8), 1995, pp. 784-792
We have tested Leukaemia Inhibitory Factor (LIF) production by 12 rat
colon tumour clones isolated from a single cell line that display vari
ous degrees of tumorigenicity A highly significant relationship was Bo
und between levels of soluble LIF produced by the clones and their in
vivo tumorigenicity, Such results suggested a role for LIF as a tumour
facilitating agent, To test this hypothesis, the highly tumorigenic a
nd LIF producing PROb clone was transfected with the LIF cDNA in antis
ense orientation in order to decrease LIF production, Conversely, REGb
, a low LIF producer that is rejected by syngeneic animals, as well as
nude mice, was transfected,vith the LIF cDNA to increase its producti
on, PROb cells transfected with antisense cDNA were shown to have decr
eased LIF production along with decreased tumorigenicity, LIF-transfec
ted REGb cells expressing high LIF levels still regressed in syngeneic
rats, but could form progressive tumours in nude mice, We did not det
ect LIF receptors on PROb or REGb cells and their in vitro proliferati
on was not modified by the addition of exogenous LIE Therefore, LIF wa
s not an autocrine growth regulator for PROb and REGb cells, Instead,
LIF appears to facilitate in vivo tumour growth, without being an immu
nosuppressive factor sufficient on its own to allow growth of immunoge
nic cells in fully immunocompetent hosts.